Kiniksa Pharmaceuticals International, plc (KNSA) Gross profit 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual gross profit history from SEC filings — each fiscal year as reported.
$599.9MFY2025 · since FY2021: $29.4M → $599.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $599.9M | +65.6% |
| FY2024 | $362.3M | +53.0% |
| FY2023 | $236.9M | +20.1% |
| FY2022 | $197.3M | +570.0% |
| FY2021 | $29.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice